T Cell and B Cell Interactions in Autoimmunity and Immune Response Publication Trend The graph below shows the total number of publications each year in T Cell and B Cell Interactions in ...

B lymphocytes exhibit dual roles in tumorigenesis, acting as both allies and adversaries in the tumor microenvironment (TME).

B-cell acute lymphoblastic leukemia (B-ALL) is the most common cancer in children, accounting for around 85% of pediatric ...

"Experts previously thought that T cells were the main orchestrators ... might be to partially mute respiration in B cells, which could then stop the cascade of interactions between immune cells ...

B-cell lymphoma doesn’t always cause symptoms ... On the other hand, targeted therapies focus on a specific interaction between cancer cells. One promising new treatment is a drug called ...

A promising lead has emerged from examining the interaction between the tumor and immune cells, including CAR-T cells. It turns out that B-ALL tumors may take advantage of the body’s natural ...

Those B cells can become malignant or cancerous, and so we treat B-cell cancers with CD19 CAR T-cell therapy. Those T cells are all now reprogrammed to fight and recognize the cancerous B cells ...

They make antibodies -- proteins that fight viruses and bacteria. B cells normally can’t cross from your blood into your brain or spinal cord. If you have MS, some B cells enter your brain and ...

Best known for producing antibodies, B cells also guide other immune cells, specifically CD8 T cells, teaching them how to mount lasting defenses after vaccination. The study was recently ...

Lymphocytes are an important part of the immune system. There are two main types of lymphocytes: B cells and T cells. Someone can develop MBL when an abnormal B-cell lymphocyte clones itself ...

Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...

Tisagenlecleucel is also approved for use in children and young adults with acute lymphoblastic B-cell leukemia. The CAR-T-cell therapies targeting B-cell maturation antigen — ciltacabtagene ...